医学
移植物抗宿主病
寄主(生物学)
超声波
皮肤病科
疾病
外科
病理
放射科
生态学
生物
作者
Elisa Molinelli,Giorgia Mancini,Valerio Brisigotti,Claudia Sapigni,Oriana Simonetti,Attilio Olivieri,Annamaria Offidani
标识
DOI:10.1016/j.jaad.2022.02.059
摘要
To the Editor: Cutaneous chronic graft-versus-host disease (cGVHD) is the most frequent manifestation of cGVHD, developing a few months/years after allogeneic hematopoietic stem cell transplants. Cutaneous cGVHD can be clinically classified as sclerotic or nonsclerotic. Sclerotic manifestations are commonly observed during the late phase of cGVHD, inducing significant morbidity, functional impairment, and prolonged immunosuppressive therapy.1 An objective, noninvasive, and early detection of skin sclerodermatous changes is essential for preventing the irreversible sequela and for monitoring treatment response.
科研通智能强力驱动
Strongly Powered by AbleSci AI